PUBLICACIONES

Analgesic Effect of a Novel Intravenous Ibuprofen-Low-Dose Tramadol Combination: A Multimodal Approach to Moderate-to-Severe Postoperative Dental Pain
Source: Alberto Borobia Published on 2025-10-29
Analgesic Effect of a Novel Intravenous Ibuprofen-Low-Dose Tramadol Combination: A Multimodal Approach to Moderate-to-Severe Postoperative Dental Pain
Source: Alberto Borobia Published on 2025-10-29
Analgesic Effect of a Novel Intravenous Ibuprofen-Low-Dose Tramadol Combination: A Multimodal Approach to Moderate-to-Severe Postoperative Dental Pain
Source: Alberto Borobia Published on 2025-10-29
Analgesic Effect of a Novel Intravenous Ibuprofen-Low-Dose Tramadol Combination: A Multimodal Approach to Moderate-to-Severe Postoperative Dental Pain
Source: Alberto Borobia Published on 2025-10-29
Analgesic Effect of a Novel Intravenous Ibuprofen-Low-Dose Tramadol Combination: A Multimodal Approach to Moderate-to-Severe Postoperative Dental Pain
Source: Alberto Borobia Published on 2025-10-29
Analgesic Effect of a Novel Intravenous Ibuprofen-Low-Dose Tramadol Combination: A Multimodal Approach to Moderate-to-Severe Postoperative Dental Pain
Source: Alberto Borobia Published on 2025-10-29
DPYD-guided fluoropyrimidine dose adjustment in colorectal cancer DPYD carriers: start slower to finish stronger
Source: Alberto Borobia Published on 2025-10-06
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial
Source: Alberto Borobia Published on 2025-03-04
The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19
Source: Alberto Borobia Published on 2025-01-29
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
Source: Alberto Borobia Published on 2025-01-14
Shaping current European mitochondrial haplogroup frequency in response to infection: the case of SARS-CoV-2 severity
Source: Alberto Borobia Published on 2025-01-09
Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial
Source: Alberto Borobia Published on 2024-11-07
Dubbing language-therapy CINEma-based in aphasia post-stroke (DULCINEA): A feasibility randomized crossover controlled trial
Source: Alberto Borobia Published on 2024-10-18
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants
Source: Alberto Borobia Published on 2024-09-17
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
Source: Alberto Borobia Published on 2024-05-30

Hospital Universitario La Paz

Servicio de Farmacología Clínica – UCICEC

Horario:

Lunes a Jueves 8.00-17.00

Viernes 8.00 - 15.00

Teléfono: 91 207 14 66

Fax: 91 207 13 84

Email: ucicec.hulp@salud.madrid.org